@article{QIMS27823,
author = {Antonio Giorgio and Massimo De Luca and Pietro Gatti and Paolo Matteucci and Valentina Giorgio},
title = {Can contrast-enhanced ultrasound with perfluorobutane add value in detection of hepatocellular carcinoma in cirrhosis during surveillance?},
journal = {Quantitative Imaging in Medicine and Surgery},
volume = {9},
number = {8},
year = {2019},
keywords = {},
abstract = {Ultrasound (US) plays a pivotal role in the recognition of hepatocellular carcinoma (HCC) in cirrhosis (1). HCC represents the sixth most common malignancy and the fourth most frequent cause of cancer-related death in the world (2). Since the early 1980s, the US has described the fundamental findings of the HCC nodules appearing in a cirrhotic liver and significantly contributed to the knowledge of the natural history of this malignancy (3).},
issn = {2223-4306}, url = {https://qims.amegroups.org/article/view/27823}
}